|
|
|
|
LEADER |
01657nmm a2200277 u 4500 |
001 |
EB002177140 |
003 |
EBX01000000000000001314674 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
231006 ||| eng |
245 |
0 |
0 |
|a Vietnam Country Case Study
|h Elektronische Ressource
|b ASEAN Vaccine Development and Manufacturing Research Project
|
260 |
|
|
|a Washington, D.C
|b The World Bank
|c 2023
|
653 |
|
|
|a Investments
|
653 |
|
|
|a Vaccine Security
|
653 |
|
|
|a Health, Nutrition and Population
|
653 |
|
|
|a Financial Viability
|
653 |
|
|
|a Value Chain
|
653 |
|
|
|a Immunizations
|
710 |
2 |
|
|a World Bank Group
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b WOBA
|a World Bank E-Library Archive
|
490 |
0 |
|
|a Other Health Study
|
028 |
5 |
0 |
|a 10.1596/40001
|
856 |
4 |
0 |
|u http://elibrary.worldbank.org/doi/book/10.1596/40001
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 330
|
520 |
|
|
|a This regional analytical activity will contribute to knowledge on the technical, operational, and financial viability and strategic partnership required among ASEAN countries to strengthen coordinated investments on the vaccine value chain. The ASA has three major activities: i) A deep-dive public sector technical assessment of country and regional level vaccine security, including gaps and opportunities across the value chain from RandD to last mile distribution; ii) A private sector value chain analysis covering upstream and downstream aspects of vaccine manufacturing; and iii) An economic analysis examining the feasibility of coordinated investments across countries to leverage comparative advantage in specific aspects of the vaccine value chain
|